Telstar will further expand its business in the Life Sciences field to provide “next-generation solutions which integrate manufacturing equipment with environmental systems, inspired by automation technologies” to markets that contribute to people’s health. It has been agreed that Japanese company Azbil will acquire an 80% stake in Telstar, S.A. from the founding shareholders (the Capella family). Ton Capella Telstar’s, Executive President, will retain a 20% equity stake in Telstar, S.A.

Based on the principles and values of Azbil, the technological and operating synergies and the complementary geographic network of sales between Azbil and Telstar, the Capella family has placed priority to the development of the Telstar businesses and all its employees ahead of maintaining control of the company. The Capella family philosophy has been to identify in Azbil the strategic business partner for Telstar to continue driving the business forward (“partnering for growth”).

Azbil is a Japanese listed corporation on the Tokyo stock exchange that provides the Building Automation business in the building market, the Advanced Automation business in the plant and factory markets, and the Life Automation business in health care, and other markets connected closely with everyday life. The values of the Azbil Group are rooted firmly in “measurement and control” technologies and the core quest of Azbil Corporation is to pursue “human-centered automation,” which strives to contribute to people’s safety, comfort and fulfillment, as well as to the global environment.

As a result of this capital participation, Telstar will become a subsidiary of Azbil Corporation. Ton Capella will continue as Managing Director and will remain a Director of the Board. Through this partnership, Azbil will strengthen its overseas sales operations by utilizing Telstar’s sales network established in the pharmaceutical, laboratory, and hospital sectors in Europe, Latin America, and North America, while Telstar will expand its business domain through Azbil’s operating bases in the Asian region, as well as strengthen its solution-providing capabilities by applying Azbil’s technologies to new product development and system integration.

Life Science Engineering business: This entity will combine Telstar’s design, engineering and manufacturing process knowledge and the Azbil Group’s automation technologies to provide new solutions that realize enhanced safety and productivity in the workplace. It will develop business globally in expanding markets, such as biopharmaceutical, life science research, personalized medicine, regenerative medicine, and functional foods, etc., and is aiming to achieve sales in excess of 200 Million Euro within five years.